Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04304703 · ClinicalTrials.gov registry record
Remote Physiologic Monitoring of Resident Wellness and Burnout
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 38
- Enrollment target
NCT04304703: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT04304703 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04304703 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Resident wellness and physician burnout are under the spotlight more and more as data begins to show that there is a point of diminishing return on the number of hours in training. In 2003, resident work hours were restricted to less than 80 hours per week averaged over 4 weeks. This change was implemented in response to the robust body of evidence that increased work hours leads to decreased sleep, which in turn leads to medical errors and depression. These factors directly and indirectly lead to worse outcomes for patients. In residency, it is difficult objectively to assess when residents are beginning to experience burnout and depression. The investigators propose a study to determine whether tracking of certain heart rate parameters (resting heart rate and heart rate variability) as well as sleep can correlate to subjective assessment of resident wellness, burnout and depression. The investigators will also compare these measures to biomarkers of stress, such as salivary cortisol. The results of this study may lead to improved understanding of what truly causes burnout and may be an eventual target for intervention to help improve short- and long-term outcomes for resident physicians as well as their patients.
Primary Outcome
Heart Rate Variability will be objectively measured nightly. Average HRV (over two weeks) will be assessed for change every two weeks over the duration of the study.
Interventions
- DEVICE WHOOP strap 3.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-07-03 |
| Est. Completion | 2021-06-30 |
What the finished NCT04304703 record still lists
NCT04304703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which WHOOP strap 3.0 is the first listed.
NCT04304703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04304703 about?
NCT04304703 is a clinical study titled "Remote Physiologic Monitoring of Resident Wellness and Burnout". Resident wellness and physician burnout are under the spotlight more and more as data begins to show that there is a point of diminishing return on the number of hours in training. In 2003, resident work hours were restricted to less than 80 hours per week averaged over 4 weeks. This change was impl...
What is the current status of trial NCT04304703?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2020-07-03. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04304703?
The interventions under investigation include: WHOOP strap 3.0 (DEVICE).
Who is sponsoring clinical trial NCT04304703?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI